NICORETTE (MINT) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nicorette (mint), and when can generic versions of Nicorette (mint) launch?
Nicorette (mint) is a drug marketed by Haleon Us Holdings and is included in two NDAs.
The generic ingredient in NICORETTE (MINT) is nicotine polacrilex. There are thirty drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nicorette (mint)
A generic version of NICORETTE (MINT) was approved as nicotine polacrilex by P AND L on March 15th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NICORETTE (MINT)?
- What are the global sales for NICORETTE (MINT)?
- What is Average Wholesale Price for NICORETTE (MINT)?
Summary for NICORETTE (MINT)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Clinical Trials: | 42 |
| DailyMed Link: | NICORETTE (MINT) at DailyMed |
-patent-expirations.png "NICORETTE (MINT) drug patent expirations")
Recent Clinical Trials for NICORETTE (MINT)
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| NYU Langone Health | Phase 1 |
| National Center for Complementary and Integrative Health (NCCIH) | Early Phase 1 |
| Washington State University | Early Phase 1 |
Pharmacology for NICORETTE (MINT)
| Drug Class | Cholinergic Nicotinic Agonist |
US Patents and Regulatory Information for NICORETTE (MINT)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | NICORETTE (MINT) | nicotine polacrilex | GUM, CHEWING;BUCCAL | 018612-003 | Dec 23, 1998 | OTC | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Haleon Us Holdings | NICORETTE (MINT) | nicotine polacrilex | GUM, CHEWING;BUCCAL | 020066-003 | Dec 23, 1998 | OTC | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for NICORETTE (MINT)
See the table below for patents covering NICORETTE (MINT) around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| European Patent Office | 1888042 | AROMATISANT POUR CHEWING GUMS CONTENANT UN MEDICAMENT (FLAVORING OF DRUG-CONTAINING CHEWING GUMS) | ⤷ Sign Up |
| South Africa | 200710905 | Flavoring of drug-containing chewing gums | ⤷ Sign Up |
| Japan | 5627851 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
